JH-RE-06
CAS: 1361227-90-8
Rif. 3D-LEC22790
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
JH-RE-06 is a drug that can be used to treat cancer. It is an inhibitor of the enzyme topoisomerase II, which is needed for replication and transcription. The death of cancer cells is due to the inhibition of DNA replication and transcription by JH-RE-06. JH-RE-06 is also mutagenic and cisplatin treatment has been shown to increase its potency. This drug has been shown to have high specificity, with only a small number of cells showing resistance. JH-RE-06 can be used as part of a therapy regimen that includes cisplatin, which may be used in combination with other drugs in order to improve efficacy. The discovery of new hallmarks for cancer cells, such as the ability to sense light or respond to changes in acidity, may lead to better ways of monitoring cancer cells and detecting tumor formation at an early stage.
Proprietà chimiche
Richiesta tecnica su: 3D-LEC22790 JH-RE-06
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
